Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50
(0.38%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma settles pending litigation with Celgene regarding generic Lenalidomide
>>
Natco Pharma gains on receiving approval for generic version of ledipasvir+sofosbuvir tablets in India
>>
Natco Pharma informs about press release
>>
Natco Pharma receives approval for generic version of ledipasvir+sofosbuvir tablets in India
>>
Natco Pharma informs about press release
>>
Natco Pharma receives approval for generic Daclatasvir Dihydrochloride tablets in India
>>
Natco Pharma rises on settling infringement suit for Generic Tamiflu
>>
Natco Pharma settles infringement suit for Generic Tamiflu
>>
Natco Pharma trades in green on the BSE
>>
Natco Pharma informs about authorized KMPs to determine materiality of events
<<
<
41
42
43
...52
>
>>